title: Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Greece: a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data.
authors.affiliation: Novartis Healthcare Pvt. Ltd., Hyderabad, India.
authors.forename: V
authors.initials: V
authors.lastname: Sonathi
authors.affiliation: Novartis Hellas, Metamorfosis, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Hatzikou
authors.affiliation: Novartis Employee by the time of the study, Horsham, UK.
authors.forename: M
authors.initials: M
authors.lastname: Baldwin
authors.affiliation: Novartis Hellas, Metamorfosis, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Panitti
authors.affiliation: Medical School University of Crete, Heraklion, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Tzortzaki